Pan HR - Search Results

1

[Establishment and application of human papillomavirus type 16 pseudovirions neutralization assay].

Lu WX, Cheng T, Li SW, Pan HR, Shen WT, Chen YX, Zhang T, Zheng Z, Zhang J, Xia NS. Lu WX, et al. Among authors: pan hr. Sheng Wu Gong Cheng Xue Bao. 2006 Nov;22(6):990-5. Sheng Wu Gong Cheng Xue Bao. 2006. PMID: 17168325 Chinese.

2

Expression and purification of soluble HIV-1 envelope glycoprotein gp160 mutant from Saccharomyces cerevisiae.

Yang K, Li S, He F, Zhang J, Wei M, Pan H, Yang C, Xiong J, Zhang J, Xia N. Yang K, et al. J Biosci Bioeng. 2009 Jul;108(1):5-10. doi: 10.1016/j.jbiosc.2009.02.009. J Biosci Bioeng. 2009. PMID: 19577184

3

[Expression, purification and immunogenicity of human papillomavirus type 11 virus-like particles from Escherichia coli].

Yan C, Li S, Wang J, Wei M, Huang B, Zhuang Y, Li Z, Pan H, Zhang J, Xia N. Yan C, et al. Wei Sheng Wu Xue Bao. 2009 Nov;49(11):1527-33. Wei Sheng Wu Xue Bao. 2009. PMID: 20112683 Chinese.

4

Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts.

Yang C, Pan H, Wei M, Zhang X, Wang N, Gu Y, Du H, Zhang J, Li S, Xia N. Yang C, et al. Protein Sci. 2013 Mar;22(3):314-26. doi: 10.1002/pro.2213. Epub 2013 Jan 17. Protein Sci. 2013. PMID: 23281113 Free PMC article.

5

Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination.

Zhao H, Lin ZJ, Huang SJ, Li J, Liu XH, Guo M, Zhang J, Xia NS, Pan HR, Wu T, Li CG. Zhao H, et al. Among authors: pan hr. Hum Vaccin Immunother. 2014;10(3):740-6. doi: 10.4161/hv.27619. Epub 2014 Jan 2. Hum Vaccin Immunother. 2014. PMID: 24384608 Free PMC article.

6

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).

Zhang X, Wei M, Pan H, Lin Z, Wang K, Weng Z, Zhu Y, Xin L, Zhang J, Li S, Xia N, Zhao Q. Zhang X, et al. Vaccine. 2014 Jul 7;32(32):4039-50. doi: 10.1016/j.vaccine.2014.05.064. Epub 2014 Jun 2. Vaccine. 2014. PMID: 24892250

7

Long-term efficacy of a hepatitis E vaccine.

Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, Guo M, Liu XH, Li JX, Yang CL, Tang Q, Jiang RJ, Pan HR, Li YM, Shih JW, Ng MH, Zhu FC, Xia NS. Zhang J, et al. Among authors: pan hr. N Engl J Med. 2015 Mar 5;372(10):914-22. doi: 10.1056/NEJMoa1406011. N Engl J Med. 2015. PMID: 25738667 Free article. Clinical Trial.

8

Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial.

Wu T, Hu YM, Li J, Chu K, Huang SJ, Zhao H, Wang ZZ, Yang CL, Jiang HM, Wang YJ, Lin ZJ, Pan HR, Sheng W, Wei FX, Li SW, Wang Y, Zhu FC, Li CG, Zhang J, Xia NS. Wu T, et al. Among authors: pan hr. Vaccine. 2015 Jul 31;33(32):3940-6. doi: 10.1016/j.vaccine.2015.06.052. Epub 2015 Jun 19. Vaccine. 2015. PMID: 26100924 Clinical Trial.

9

Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity.

Pan H, Li Z, Wang J, Song S, Wang D, Wei M, Gu Y, Zhang J, Li S, Xia N. Pan H, et al. Vaccine. 2017 May 31;35(24):3222-3231. doi: 10.1016/j.vaccine.2017.04.064. Epub 2017 May 5. Vaccine. 2017. PMID: 28483196

10

Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.

Gu Y, Wei M, Wang D, Li Z, Xie M, Pan H, Wu T, Zhang J, Li S, Xia N. Gu Y, et al. Vaccine. 2017 Aug 16;35(35 Pt B):4637-4645. doi: 10.1016/j.vaccine.2017.06.084. Epub 2017 Jul 20. Vaccine. 2017. PMID: 28736197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters